Dorothea Bankwitz

1.5k total citations
21 papers, 1.1k citations indexed

About

Dorothea Bankwitz is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Dorothea Bankwitz has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 15 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in Dorothea Bankwitz's work include Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (9 papers). Dorothea Bankwitz is often cited by papers focused on Hepatitis C virus research (19 papers), Liver Disease Diagnosis and Treatment (11 papers) and Hepatitis B Virus Studies (9 papers). Dorothea Bankwitz collaborates with scholars based in Germany, France and United States. Dorothea Bankwitz's co-authors include Thomas Pietschmann, Thomas Pietschmann, Sibylle Haid, Kathrin Hueging, Anne Frentzen, Mirjam B. Zeisel, Julia Bitzegeio, Thomas F. Baumert, Eike Steinmann and Eva Herrmann and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Dorothea Bankwitz

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dorothea Bankwitz Germany	16	742	619	183	168	120	21	1.1k
Meital Gal-Tanamy Israel	15	435 0.6×	392 0.6×	187 1.0×	181 1.1×	66 0.6×	28	954
Véronique Descamps France	20	916 1.2×	761 1.2×	230 1.3×	254 1.5×	165 1.4×	35	1.5k
Anne Frentzen Germany	11	345 0.5×	329 0.5×	32 0.2×	139 0.8×	56 0.5×	11	633
Tsuyoshi Adachi Japan	12	694 0.9×	406 0.7×	176 1.0×	370 2.2×	94 0.8×	20	1.2k
Niki Vassilaki Greece	17	464 0.6×	344 0.6×	70 0.4×	194 1.2×	64 0.5×	54	888
Kaku Goto Japan	21	752 1.0×	596 1.0×	26 0.1×	391 2.3×	86 0.7×	41	1.4k
Anggakusuma Germany	15	299 0.4×	221 0.4×	15 0.1×	181 1.1×	39 0.3×	21	783
Torahiko Tanaka Japan	16	751 1.0×	608 1.0×	114 0.6×	279 1.7×	33 0.3×	28	1.3k
Mami Matsuda Japan	20	385 0.5×	401 0.6×	47 0.3×	363 2.2×	77 0.6×	42	1.1k
Juliane Gentzsch Germany	12	292 0.4×	244 0.4×	38 0.2×	119 0.7×	43 0.4×	12	523

Countries citing papers authored by Dorothea Bankwitz

Since Specialization

Citations

This map shows the geographic impact of Dorothea Bankwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothea Bankwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothea Bankwitz more than expected).

Fields of papers citing papers by Dorothea Bankwitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothea Bankwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothea Bankwitz. The network helps show where Dorothea Bankwitz may publish in the future.

Co-authorship network of co-authors of Dorothea Bankwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothea Bankwitz. A scholar is included among the top collaborators of Dorothea Bankwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothea Bankwitz. Dorothea Bankwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bankwitz, Dorothea, Maurice Labuhn, Daniel Tödt, et al.. (2020). Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies. Gut. 70(9). 1734–1745. 19 indexed citations

Bankwitz, Dorothea, Kathrin Hueging, Romy Weller, et al.. (2017). Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity. Journal of Hepatology. 67(3). 480–489. 47 indexed citations

Vasiliauskaité-Brooks, Ieva, Patrick England, Abdul Ghafoor Khan, et al.. (2017). Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2. mBio. 8(3). 30 indexed citations

Hedenstierna, Magnus, Ola Weiland, Dorothea Bankwitz, et al.. (2015). Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure. Alimentary Pharmacology & Therapeutics. 41(6). 532–543. 7 indexed citations

Haid, Sibylle, et al.. (2015). Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System. Journal of Virology. 90(6). 3065–3073. 25 indexed citations

Fiedler, Melanie, Dorothea Bankwitz, William O. Osburn, et al.. (2014). Hepatitis C Virus Hypervariable Region 1 Variants Presented on Hepatitis B Virus Capsid-Like Particles Induce Cross-Neutralizing Antibodies. PLoS ONE. 9(7). e102235–e102235. 7 indexed citations

Bankwitz, Dorothea, Gabrielle Vièyres, Kathrin Hueging, et al.. (2014). Role of Hypervariable Region 1 for the Interplay of Hepatitis C Virus with Entry Factors and Lipoproteins. Journal of Virology. 88(21). 12644–12655. 41 indexed citations

Vercauteren, Koen, Ahmed Atef Mesalam, Sandrine Belouzard, et al.. (2014). Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents. Hepatology. 60(5). 1508–1518. 50 indexed citations

Hueging, Kathrin, Gabrielle Vièyres, Dorothea Bankwitz, et al.. (2013). Apolipoprotein E Codetermines Tissue Tropism of Hepatitis C Virus and Is Crucial for Viral Cell-to-Cell Transmission by Contributing to a Postenvelopment Step of Assembly. Journal of Virology. 88(3). 1433–1446. 87 indexed citations

10.

Anggakusuma, Che C. Colpitts, Luis M. Schang, et al.. (2013). Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 63(7). 1137–1149. 160 indexed citations

11.

Rachmawati, Heni, Anne Frentzen, Stephanie Pfaender, et al.. (2013). 1162 TURMERIC CURCUMIN INHIBITS ENTRY OF ALL HEPATITIS C VIRUS GENOTYPES INTO HUMAN LIVER CELLS. Journal of Hepatology. 58. S473–S473. 15 indexed citations

12.

Haid, Sibylle, Juliane Gentzsch, Dorothea Bankwitz, et al.. (2012). A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes. Gastroenterology. 143(1). 213–222.e5. 94 indexed citations

13.

Menzel, Nicolas, Wolfgang Fischl, Kathrin Hueging, et al.. (2012). MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles. PLoS Pathogens. 8(7). e1002829–e1002829. 110 indexed citations

14.

Chhatwal, Patrick, Dorothea Bankwitz, Juliane Gentzsch, et al.. (2012). Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication. PLoS ONE. 7(4). e36029–e36029. 21 indexed citations

15.

Westhaus, Sandra, Dorothea Bankwitz, Stefanie Ernst, et al.. (2012). Characterization of the inhibition of hepatitis C virus entry by In vitro –generated and patient-derived oxidized low-density lipoprotein. Hepatology. 57(5). 1716–1724. 11 indexed citations

16.

Ciesek, Sandra, Dorothea Bankwitz, Maren Luchtefeld, et al.. (2012). 877 OXIDIZED LOW DENSITY LIPOPROTEIN (OXLDL) IS A PAN-GENOTYPE INHIBITOR OF HCV ENTRY THAT ACTS IN A SR-BI DEPENDENT MANNER. Journal of Hepatology. 56. S341–S342. 1 indexed citations

17.

Zahid, Muhammad, Marine Turek, Fei Xiao, et al.. (2012). The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination. Hepatology. 57(2). 492–504. 60 indexed citations

18.

Ruhl, Marianne, Patrick Chhatwal, Heiko Strathmann, et al.. (2011). Escape from a Dominant HLA-B*15-Restricted CD8 ⁺ T Cell Response against Hepatitis C Virus Requires Compensatory Mutations outside the Epitope. Journal of Virology. 86(2). 991–1000. 19 indexed citations

19.

Bitzegeio, Julia, Dorothea Bankwitz, Kathrin Hueging, et al.. (2010). Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors. PLoS Pathogens. 6(7). e1000978–e1000978. 90 indexed citations

20.

Bankwitz, Dorothea, Eike Steinmann, Julia Bitzegeio, et al.. (2010). Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes. Journal of Virology. 84(11). 5751–5763. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact